0.56
-0.0091(-1.59%)
Currency In USD
| Previous Close | 0.57 |
| Open | 0.56 |
| Day High | 0.58 |
| Day Low | 0.53 |
| 52-Week High | 21.5 |
| 52-Week Low | 0.48 |
| Volume | 105,226 |
| Average Volume | 498,841 |
| Market Cap | 2.87M |
| PE | -0.12 |
| EPS | -4.74 |
| Moving Average 50 Days | 0.6 |
| Moving Average 200 Days | 4.71 |
| Change | -0.01 |
If you invested $1000 in Matinas BioPharma Holdings, Inc. (MTNB) 10 years ago, it would be worth $17.93 as of February 05, 2025 at a share price of $0.565. Whereas If you bought $1000 worth of Matinas BioPharma Holdings, Inc. (MTNB) shares 5 years ago, it would be worth $8.25 as of February 05, 2025 at a share price of $0.565.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Matinas BioPharma Receives NYSE Noncompliance Notice
GlobeNewswire Inc.
Jan 10, 2025 10:15 PM GMT
BEDMINSTER, N.J. , Jan. 10, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that on January 6, 2025, it received a NYSE American LLC notice indicating that the Company has fallen below certain NYSE American
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
GlobeNewswire Inc.
Oct 31, 2024 10:30 AM GMT
BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet regarding global rights to MAT2203, its oral formulation of